nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefradine—CYP3A4—prostate cancer	0.332	1	CbGaD
Cefradine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.104	0.178	CbGbCtD
Cefradine—SLC22A6—Conjugated Estrogens—prostate cancer	0.0801	0.138	CbGbCtD
Cefradine—CYP3A4—Bicalutamide—prostate cancer	0.0545	0.0937	CbGbCtD
Cefradine—CYP3A4—Estramustine—prostate cancer	0.0507	0.0871	CbGbCtD
Cefradine—CYP3A4—Abiraterone—prostate cancer	0.0452	0.0776	CbGbCtD
Cefradine—CYP3A4—Flutamide—prostate cancer	0.0452	0.0776	CbGbCtD
Cefradine—CYP3A4—Cabazitaxel—prostate cancer	0.0334	0.0574	CbGbCtD
Cefradine—CYP3A4—Estrone—prostate cancer	0.0327	0.0561	CbGbCtD
Cefradine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0291	0.05	CbGbCtD
Cefradine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0214	0.0367	CbGbCtD
Cefradine—CYP3A4—Mitoxantrone—prostate cancer	0.0194	0.0334	CbGbCtD
Cefradine—CYP3A4—Estradiol—prostate cancer	0.0188	0.0322	CbGbCtD
Cefradine—CYP3A4—Prednisone—prostate cancer	0.0161	0.0277	CbGbCtD
Cefradine—CYP3A4—Etoposide—prostate cancer	0.0123	0.021	CbGbCtD
Cefradine—CYP3A4—Docetaxel—prostate cancer	0.0112	0.0193	CbGbCtD
Cefradine—CYP3A4—Doxorubicin—prostate cancer	0.00836	0.0144	CbGbCtD
Cefradine—CYP3A4—urine—prostate cancer	0.00163	0.136	CbGeAlD
Cefradine—Cefazolin—PON1—prostate cancer	0.00149	0.466	CrCbGaD
Cefradine—SLC15A1—epithelium—prostate cancer	0.00121	0.101	CbGeAlD
Cefradine—SLC15A1—renal system—prostate cancer	0.00112	0.0936	CbGeAlD
Cefradine—SLC15A2—prostate gland—prostate cancer	0.00103	0.0859	CbGeAlD
Cefradine—SLC22A5—prostate gland—prostate cancer	0.000893	0.0747	CbGeAlD
Cefradine—SLC15A2—seminal vesicle—prostate cancer	0.000868	0.0726	CbGeAlD
Cefradine—SLC22A5—seminal vesicle—prostate cancer	0.000755	0.0632	CbGeAlD
Cefradine—SLC15A2—renal system—prostate cancer	0.0007	0.0585	CbGeAlD
Cefradine—SLC15A2—urethra—prostate cancer	0.000687	0.0575	CbGeAlD
Cefradine—Cefdinir—MPO—prostate cancer	0.000609	0.191	CrCbGaD
Cefradine—SLC22A5—renal system—prostate cancer	0.000609	0.0509	CbGeAlD
Cefradine—Cefaclor—MPO—prostate cancer	0.000604	0.189	CrCbGaD
Cefradine—SLC22A5—urethra—prostate cancer	0.000598	0.05	CbGeAlD
Cefradine—SLC15A2—testis—prostate cancer	0.000452	0.0378	CbGeAlD
Cefradine—CYP3A4—renal system—prostate cancer	0.000399	0.0334	CbGeAlD
Cefradine—SLC22A5—testis—prostate cancer	0.000393	0.0329	CbGeAlD
Cefradine—Amoxicillin—CYP2C19—prostate cancer	0.000348	0.109	CrCbGaD
Cefradine—SLC15A2—lymph node—prostate cancer	0.000328	0.0274	CbGeAlD
Cefradine—SLC22A5—lymph node—prostate cancer	0.000285	0.0239	CbGeAlD
Cefradine—Cephalexin—CYP3A4—prostate cancer	0.000143	0.0449	CrCbGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.00013	0.00184	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000128	0.00182	CbGpPWpGaD
Cefradine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000126	0.00178	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000124	0.00175	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	0.00012	0.00169	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	0.00012	0.00169	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000118	0.00167	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	0.000118	0.00167	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000115	0.00163	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000114	0.00162	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000113	0.0016	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTM3—prostate cancer	0.000113	0.00159	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	0.000113	0.00159	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	0.000111	0.00157	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	0.000111	0.00157	CbGpPWpGaD
Cefradine—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	0.000109	0.00155	CbGpPWpGaD
Cefradine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000109	0.00154	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000108	0.00153	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	0.000108	0.00153	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	0.000107	0.00151	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—NAT1—prostate cancer	0.000107	0.00151	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	0.000106	0.00151	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000106	0.0015	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	0.000106	0.00149	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	0.000105	0.00149	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000105	0.00149	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000105	0.00149	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000104	0.00148	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	0.000104	0.00147	CbGpPWpGaD
Cefradine—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	0.000104	0.00147	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.000103	0.00145	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000101	0.00143	CbGpPWpGaD
Cefradine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	9.99e-05	0.00141	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	9.97e-05	0.00141	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	9.84e-05	0.00139	CbGpPWpGaD
Cefradine—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	9.76e-05	0.00138	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	9.61e-05	0.00136	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	9.5e-05	0.00134	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.37e-05	0.00133	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.22e-05	0.0013	CbGpPWpGaD
Cefradine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	9.16e-05	0.0013	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	8.95e-05	0.00127	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	8.92e-05	0.00126	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	8.85e-05	0.00125	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—GNG5—prostate cancer	8.77e-05	0.00124	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	8.74e-05	0.00124	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	8.73e-05	0.00124	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	8.54e-05	0.00121	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	8.44e-05	0.00119	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	8.39e-05	0.00119	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	8.3e-05	0.00117	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	8.28e-05	0.00117	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	8.19e-05	0.00116	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	8.19e-05	0.00116	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	8.09e-05	0.00114	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	8.08e-05	0.00114	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	8e-05	0.00113	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	7.98e-05	0.00113	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	7.89e-05	0.00112	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.88e-05	0.00111	CbGpPWpGaD
Cefradine—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	7.86e-05	0.00111	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	7.78e-05	0.0011	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.72e-05	0.00109	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	7.7e-05	0.00109	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	7.61e-05	0.00108	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.6e-05	0.00108	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.48e-05	0.00106	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	7.37e-05	0.00104	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	7.17e-05	0.00101	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.17e-05	0.00101	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	7.12e-05	0.00101	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.05e-05	0.000997	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	7.02e-05	0.000993	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.96e-05	0.000984	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTA3—prostate cancer	6.88e-05	0.000973	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.84e-05	0.000967	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	6.8e-05	0.000962	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	6.78e-05	0.000959	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.73e-05	0.000951	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	6.62e-05	0.000936	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.51e-05	0.000921	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	6.49e-05	0.000918	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	6.39e-05	0.000904	CbGpPWpGaD
Cefradine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	6.36e-05	0.000899	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTA4—prostate cancer	6.29e-05	0.00089	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	6.29e-05	0.00089	CbGpPWpGaD
Cefradine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	6.27e-05	0.000888	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	6.2e-05	0.000877	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	6.19e-05	0.000876	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	6.17e-05	0.000873	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTA2—prostate cancer	6.13e-05	0.000867	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	6.05e-05	0.000856	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.04e-05	0.000855	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	5.97e-05	0.000845	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.94e-05	0.00084	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTA1—prostate cancer	5.91e-05	0.000837	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—NAT2—prostate cancer	5.85e-05	0.000827	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTO1—prostate cancer	5.85e-05	0.000827	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	5.77e-05	0.000816	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	5.77e-05	0.000816	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	5.75e-05	0.000813	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—RXRA—prostate cancer	5.65e-05	0.000799	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.64e-05	0.000798	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	5.61e-05	0.000793	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	5.53e-05	0.000782	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.32e-05	0.000753	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	5.21e-05	0.000737	CbGpPWpGaD
Cefradine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	5.15e-05	0.000729	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	5.14e-05	0.000727	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.08e-05	0.000718	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	4.9e-05	0.000694	CbGpPWpGaD
Cefradine—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	4.85e-05	0.000686	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.73e-05	0.000669	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—HPGDS—prostate cancer	4.67e-05	0.000661	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	4.65e-05	0.000657	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	4.58e-05	0.000648	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTT1—prostate cancer	4.53e-05	0.000641	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.48e-05	0.000634	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	4.48e-05	0.000634	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.39e-05	0.000621	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	4.32e-05	0.000611	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	4.3e-05	0.000608	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	4.29e-05	0.000607	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	4.27e-05	0.000603	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	4.23e-05	0.000599	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—NCOA2—prostate cancer	4.09e-05	0.000578	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.81e-05	0.000539	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.76e-05	0.000532	CbGpPWpGaD
Cefradine—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.76e-05	0.000531	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.61e-05	0.000511	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	3.56e-05	0.000504	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GGT1—prostate cancer	3.5e-05	0.000495	CbGpPWpGaD
Cefradine—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.49e-05	0.000493	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—NCOA1—prostate cancer	3.45e-05	0.000487	CbGpPWpGaD
Cefradine—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.43e-05	0.000485	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	3.4e-05	0.00048	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	3.35e-05	0.000474	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—RXRA—prostate cancer	3.28e-05	0.000464	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	3.26e-05	0.000461	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—COMT—prostate cancer	3.16e-05	0.000447	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	3.14e-05	0.000445	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	3.11e-05	0.000441	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	3.1e-05	0.000438	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.89e-05	0.000409	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.85e-05	0.000403	CbGpPWpGaD
Cefradine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.74e-05	0.000387	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HAO1—prostate cancer	2.7e-05	0.000382	CbGpPWpGaD
Cefradine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.7e-05	0.000382	CbGpPWpGaD
Cefradine—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.59e-05	0.000366	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CSAD—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PSAT1—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TST—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GRHL1—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ADI1—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CBR1—prostate cancer	2.2e-05	0.000312	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—UGT2B15—prostate cancer	2.05e-05	0.00029	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—UGT2B17—prostate cancer	2.05e-05	0.00029	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GRHPR—prostate cancer	2.05e-05	0.00029	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CKMT2—prostate cancer	2.05e-05	0.00029	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—RFK—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—AOX1—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.93e-05	0.000272	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.83e-05	0.000258	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—AMACR—prostate cancer	1.83e-05	0.000258	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.83e-05	0.000258	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NAT1—prostate cancer	1.83e-05	0.000258	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.83e-05	0.000258	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.74e-05	0.000246	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.55e-05	0.00022	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HPGD—prostate cancer	1.55e-05	0.00022	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.46e-05	0.000206	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.42e-05	0.000201	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—MTAP—prostate cancer	1.42e-05	0.000201	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.38e-05	0.000196	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.38e-05	0.000196	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.32e-05	0.000187	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.32e-05	0.000187	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—UMPS—prostate cancer	1.27e-05	0.000179	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.27e-05	0.000179	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ARG2—prostate cancer	1.27e-05	0.000179	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—LDHB—prostate cancer	1.24e-05	0.000175	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.22e-05	0.000172	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PDHA1—prostate cancer	1.18e-05	0.000166	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTA3—prostate cancer	1.18e-05	0.000166	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—UCP3—prostate cancer	1.18e-05	0.000166	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TCN2—prostate cancer	1.18e-05	0.000166	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.12e-05	0.000159	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.12e-05	0.000159	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTA4—prostate cancer	1.08e-05	0.000152	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.08e-05	0.000152	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTA2—prostate cancer	1.05e-05	0.000148	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ABCG5—prostate cancer	1.04e-05	0.000146	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.04e-05	0.000146	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTA1—prostate cancer	1.01e-05	0.000143	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HSD3B2—prostate cancer	1e-05	0.000141	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTO1—prostate cancer	1e-05	0.000141	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NAT2—prostate cancer	1e-05	0.000141	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PLCB2—prostate cancer	9.59e-06	0.000136	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—LRP2—prostate cancer	9.59e-06	0.000136	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP2C18—prostate cancer	9.59e-06	0.000136	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—P4HB—prostate cancer	9.4e-06	0.000133	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.15e-06	0.000129	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.91e-06	0.000126	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—MED12—prostate cancer	8.77e-06	0.000124	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GNG5—prostate cancer	8.7e-06	0.000123	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NCOA3—prostate cancer	8.38e-06	0.000119	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—HPGDS—prostate cancer	7.99e-06	0.000113	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.94e-06	0.000112	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTT1—prostate cancer	7.75e-06	0.00011	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ACHE—prostate cancer	7.75e-06	0.00011	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.66e-06	0.000108	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.46e-06	0.000105	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PRKACB—prostate cancer	7.42e-06	0.000105	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.34e-06	0.000104	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NCOA2—prostate cancer	6.99e-06	9.89e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.67e-06	9.44e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.52e-06	9.22e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NQO1—prostate cancer	6.44e-06	9.12e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TH—prostate cancer	6.35e-06	8.98e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.18e-06	8.74e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GGT1—prostate cancer	5.98e-06	8.46e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NCOA1—prostate cancer	5.89e-06	8.34e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.81e-06	8.22e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—RXRA—prostate cancer	5.61e-06	7.93e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—COMT—prostate cancer	5.4e-06	7.64e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTP1—prostate cancer	5.37e-06	7.6e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ITPR1—prostate cancer	5.29e-06	7.48e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—TYMS—prostate cancer	5e-06	7.07e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—GSTM1—prostate cancer	4.94e-06	6.99e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—LPL—prostate cancer	4.85e-06	6.86e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.68e-06	6.62e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—ERCC2—prostate cancer	4.64e-06	6.57e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.36e-06	6.17e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PPARA—prostate cancer	4.28e-06	6.06e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CAV1—prostate cancer	4.03e-06	5.7e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.67e-06	5.19e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—INS—prostate cancer	3.47e-06	4.91e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.4e-06	4.81e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.22e-06	4.56e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—NOS3—prostate cancer	3.04e-06	4.31e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.81e-06	3.97e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.78e-06	3.94e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PTEN—prostate cancer	2.43e-06	3.43e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—EP300—prostate cancer	2.32e-06	3.28e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.71e-06	2.42e-05	CbGpPWpGaD
Cefradine—CYP3A4—Metabolism—AKT1—prostate cancer	1.4e-06	1.98e-05	CbGpPWpGaD
